S21-215 Methods for Diagnosing and Treating Ischemic Eye Disease Stanford researchers in the Mahajan Lab have created a customizable proteomics platform that can identify protein biomarkers to differentiate among ischemic eye diseases and identify novel therapeutic targets to treat them. Gabriel Velez Vinit Mahajan Cassie Ludwig